Stay updated on Pembrolizumab for Lung Cancer Prevention Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.

Latest updates to the Pembrolizumab for Lung Cancer Prevention Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to the study details or page behavior.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded study locations: New York and Texas. Last Update Posted (Estimated) date was updated.SummaryDifference0.7%

- Check55 days agoChange DetectedThe page revision label changes from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe government funding notice banner at the top of the page was removed. There are no changes to the study details or other content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check77 days agoChange DetectedThe core study information and sections (Overview, Eligibility Criteria, Study Plan, and Outcomes) remain unchanged across the screenshots; only formatting differences are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check105 days agoChange DetectedImportant updates include a notice about government funding impacts and operating status, plus a new version (v3.2.0); the old version tag (v3.1.0) was removed. If no other major content changes are present, this represents an operational update rather than a broad content overhaul.SummaryDifference2%

Stay in the know with updates to Pembrolizumab for Lung Cancer Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Lung Cancer Prevention Clinical Trial page.